Ingevity CorporationNGVTNYSE
LOADING
|||
R&D Expense Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-10.26%
↓ 624% below average
Average (39q)
1.96%
Historical baseline
Range
High:114.47%
Low:-46.01%
Volatility
8197.5%
High variability
| Period | Value |
|---|---|
| Q3 2025 | -10.26% |
| Q2 2025 | 1.30% |
| Q1 2025 | 5.48% |
| Q4 2024 | 8.96% |
| Q3 2024 | -8.22% |
| Q2 2024 | 7.35% |
| Q1 2024 | -5.56% |
| Q4 2023 | -7.69% |
| Q3 2023 | -2.50% |
| Q2 2023 | -9.09% |
| Q1 2023 | -46.01% |
| Q4 2022 | 114.47% |
| Q3 2022 | -7.32% |
| Q2 2022 | 12.33% |
| Q1 2022 | 4.29% |
| Q4 2021 | 2.94% |
| Q3 2021 | 15.25% |
| Q2 2021 | -10.61% |
| Q1 2021 | 13.79% |
| Q4 2020 | 11.54% |
| Q3 2020 | -3.70% |
| Q2 2020 | -12.90% |
| Q1 2020 | 31.91% |
| Q4 2019 | -4.08% |
| Q3 2019 | -2.00% |
| Q2 2019 | -1.96% |
| Q1 2019 | -1.92% |
| Q4 2018 | -7.14% |
| Q3 2018 | 5.66% |
| Q2 2018 | 6.00% |
| Q1 2018 | -3.85% |
| Q4 2017 | 8.33% |
| Q3 2017 | 2.13% |
| Q2 2017 | -7.84% |
| Q1 2017 | 15.91% |
| Q4 2016 | 12.82% |
| Q3 2016 | -15.22% |
| Q2 2016 | 0.00% |
| Q1 2016 | -34.29% |
| Q4 2015 | 0.00% |